These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 30358895)

  • 1. Paediatric-onset and adult-onset Graves' disease share multiple genetic risk factors.
    Kuś A; Radziszewski M; Glina A; Szymański K; Jurecka-Lubieniecka B; Pawlak-Adamska E; Kula D; Wawrusiewicz-Kurylonek N; Kuś J; Miśkiewicz P; Płoski R; Bolanowski M; Daroszewski J; Jarząb B; Bossowski A; Bednarczuk T
    Clin Endocrinol (Oxf); 2019 Feb; 90(2):320-327. PubMed ID: 30358895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Intronic HCP5 Variant Is Associated With Age of Onset and Susceptibility to Graves Disease in UK and Polish Cohorts.
    Lane LC; Kuś A; Bednarczuk T; Bossowski A; Daroszewski J; Jurecka-Lubieniecka B; Cordell HJ; Pearce SHS; Cheetham T; Mitchell AL
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3277-84. PubMed ID: 32501499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of thyroid peroxidase antibody risk loci with susceptibility to and phenotype of Graves' disease.
    Kuś A; Szymański K; Peeters RP; Miśkiewicz P; Porcu E; Pistis G; Sanna S; Naitza S; Płoski R; Medici M; Bednarczuk T
    Clin Endocrinol (Oxf); 2015 Oct; 83(4):556-62. PubMed ID: 25345847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of HLA-DRB1* alleles and CTLA4 (+49 AG) gene polymorphism in Autoimmune Thyroid Disease.
    Ramgopal S; Rathika C; Padma MR; Murali V; Arun K; Kamaludeen MN; Balakrishnan K
    Gene; 2018 Feb; 642():430-438. PubMed ID: 29174716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.
    Skórka A; Bednarczuk T; Bar-Andziak E; Nauman J; Ploski R
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):679-82. PubMed ID: 15943829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Gene-Gene Interactions in Graves' Disease Patients Stratified by Age of Onset.
    Jurecka-Lubieniecka B; Bednarczuk T; Ploski R; Krajewska J; Kula D; Kowalska M; Tukiendorf A; Kolosza Z; Jarzab B
    PLoS One; 2016; 11(3):e0150307. PubMed ID: 26943356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of IL37 gene as a protective factor for autoimmune thyroid disease.
    Yan N; Meng S; Song RH; Qin Q; Wang X; Yao Q; Jiang Y; Jiang W; Shi L; Xu J; Zhang J
    J Mol Endocrinol; 2015 Dec; 55(3):209-18. PubMed ID: 26373794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA alleles, especially amino-acid signatures of HLA-DPB1, might contribute to the molecular pathogenesis of early-onset autoimmune thyroid disease.
    Shin DH; Baek IC; Kim HJ; Choi EJ; Ahn M; Jung MH; Suh BK; Cho WK; Kim TG
    PLoS One; 2019; 14(5):e0216941. PubMed ID: 31091281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease.
    Fujii A; Inoue N; Watanabe M; Kawakami C; Hidaka Y; Hayashizaki Y; Iwatani Y
    Thyroid; 2017 Jan; 27(1):111-119. PubMed ID: 27762730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The -112G>A polymorphism of the secretoglobin 3A2 (SCGB3A2) gene encoding uteroglobin-related protein 1 (UGRP1) increases risk for the development of Graves' disease in subsets of patients with elevated levels of immunoglobulin E.
    Chistiakov DA; Voronova NV; Turakulov RI; Savost'anov KV
    J Appl Genet; 2011 May; 52(2):201-7. PubMed ID: 21170691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of IKZF3 Gene and Autoimmune Thyroid Diseases: Associated with Graves' Disease but Not with Hashimoto's Thyroiditis.
    Li L; Ding X; Wang X; Yao Q; Shao X; An X; Yan N; Jiang Y; Wang W; Shi L; Qin Q; Song R; Zhang JA; Sun P
    Cell Physiol Biochem; 2018; 45(5):1787-1796. PubMed ID: 29510406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in MIR499A and MIR125A gene are associated with autoimmune thyroid diseases.
    Cai T; Li J; An X; Yan N; Li D; Jiang Y; Wang W; Shi L; Qin Q; Song R; Wang G; Jiang W; Zhang JA
    Mol Cell Endocrinol; 2017 Jan; 440():106-115. PubMed ID: 27888002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study.
    Kurylowicz A; Ramos-Lopez E; Bednarczuk T; Badenhoop K
    Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):329-35. PubMed ID: 16868893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between age at diagnosis of Graves' disease and variants in genes involved in immune response.
    Jurecka-Lubieniecka B; Ploski R; Kula D; Krol A; Bednarczuk T; Kolosza Z; Tukiendorf A; Szpak-Ulczok S; Stanjek-Cichoracka A; Polanska J; Jarzab B
    PLoS One; 2013; 8(3):e59349. PubMed ID: 23544060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor polymorphisms increase the risk of developing Graves' disease.
    Vural P; Baki M; Doğru-Abbasoğlu S; Özderya A; Karadağ B; Uysal M
    Int Immunopharmacol; 2012 Oct; 14(2):133-7. PubMed ID: 22771446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association of IRF5 gene polymorphisms with autoimmune thyroid disease: a case-control study. IRF5 gene and AITD.
    Muhali FS; Zhou-jiao Z; Wang Y; Wang Q; Shi XH; Jiang WJ; Xiao L; Li DF; He ST; Xu J; Zhang JA
    Ann Endocrinol (Paris); 2014 Feb; 75(1):19-24. PubMed ID: 24582590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of CTLA-4 +49 A/G and CT60 Gene Polymorphism with Graves' Disease.
    Fouad NA; Saeed AM; Mahedy AW
    Egypt J Immunol; 2017 Jun; 24(2):63-70. PubMed ID: 29528580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective.
    Chen QY; Huang W; She JX; Baxter F; Volpe R; Maclaren NK
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3182-6. PubMed ID: 10487684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional SNPs in the SCGB3A2 promoter are associated with susceptibility to Graves' disease.
    Song HD; Liang J; Shi JY; Zhao SX; Liu Z; Zhao JJ; Peng YD; Gao GQ; Tao J; Pan CM; Shao L; Cheng F; Wang Y; Yuan GY; Xu C; Han B; Huang W; Chu X; Chen Y; Sheng Y; Li RY; Su Q; Gao L; Jia WP; Jin L; Chen MD; Chen SJ; Chen Z; Chen JL
    Hum Mol Genet; 2009 Mar; 18(6):1156-70. PubMed ID: 19126779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.